OCT in Rare Chorioretinal Diseases

RecruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Retinal Artery OcclusionsPolypoidal Choroidal VasculopathyRetinal Arterial MacroaneurysmJuxtafoveal TelangiecasiaCentral Serous Chorioretinopathy

Trial Locations (1)

RECRUITING

Casey Eye Institute, Oregon Health & Science University, Portland

All Listed Sponsors

lead

Oregon Health and Science University

OTHER